Follow

Submissions from 2022

Link

Labile Heme and Heme Oxygenase-1 Maintain Tumor-Permissive Niche for Endometriosis-Associated Ovarian Cancer, Jonathan L. Hecht, Monika Janikova, Reeham Choudhury, Fong Liu, Giacomo Canesin, Lubica Janovicova, Eva Csizmadia, Elisa M. Jorgensen, Katharine M. Esselen, Peter Celec, Kenneth D. Swanson, and Barbara Wegiel

Link

Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III-IV melanoma in phase III trial E1609, Laurie E. McLouth, Yue Zheng, Stephanie Smith, F Stephen Hodi, Uma N. Rao, Gary I. Cohen, Thomas T. Amatruda, Shaker R. Dakhill, Brendan D. Curti, Ibrahim Nakhoul, Sreenivasa R. Chandana, Charles L. Bane, David E. Mariner, Sandra J. Lee, Vernon K. Sondak, John M. Kirkwood, Ahmad A. Tarhini, and Lynn I. Wagner

Link

Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Navneet Singh, Sarah Temin, Sherman Baker Jr, Elizabeth Blanchard, Julie R. Brahmer, Paul Celano, Narjust Duma, Peter M. Ellis, Ivy B. Elkins, Rami Y. Haddad, Paul J. Hesketh, Dharamvir Jain, David H. Johnson, Natasha B. Leighl, Hirva Mamdani, Gregory Masters, Pamela R. Moffitt, Tanyanika Phillips, Gregory J. Riely, and Andrew G. Robinson

Link

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Navneet Singh, Sarah Temin, Sherman Baker Jr, Elizabeth Blanchard, Julie R. Brahmer, Paul Celano, Narjust Duma, Peter M. Ellis, Ivy B. Elkins, Rami Y. Haddad, Paul J. Hesketh, Dharamvir Jain, David H. Johnson, Natasha B. Leighl, Hirva Mamdani, Gregory Masters, Pamela R. Moffitt, Tanyanika Phillips, Gregory J. Riely, and Andrew G. Robinson

Submissions from 2021

Link

A Translational Approach to Cancer Research, Education and Training, Heather J. Ezelle, Theresa Geiman, Lauren A. Schnaper, Kevin J. Cullen, Rena S. Lapidus, and Bret A. Hassel

Submissions from 2020

Link

Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis, Paul Celano

Submissions from 2017

Link

Genomic alterations in human epidermal growth factor receptor 2 (HER2/ERBB2) in head and neck squamous cell carcinoma, Christine H. Chung, Alexis Germain, Rathan M. Subramaniam, Andreas M. Heilmann, Kyle Fedorchak, Siraj M. Ali, Vincent A. Miller, Robert A. Palermo, and Carole Fakhry

Link

Summary of the Workshop on the Safe Handling of Hazardous Drugs Cohosted by the National Institute for Occupational Safety and Health and the American Society of Clinical Oncology, Thomas H. Connor, Paul Celano, James N. Frame, and Robin T. Zon

Link

Management of sickle cell disease in patients undergoing cardiac surgery, Todd C. Crawford, Michael V. Carter, Rina K. Patel, Alejandro Suarez-Pierre, Sophie Z. Lin, Jonathan Trent Magruder, Joshua C. Grimm, Duke E. Cameron, William A. Baumgartner, and Kaushik Mandal

Submissions from 2016

Link

Case Report: Collision Tumour of Colon Leiomyosarcoma and Adenocarcinoma, Victoria M. Kim, Lindsay Goicochea, and Sandy H. Fang

Submissions from 2015

Link

Randomized, Placebo-Controlled, Phase III Trial of Yeast-Derived Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With No Evidence of Disease After Complete Surgical Resection of Locally Advanced and/or Stage IV Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E4697), David H. Lawson, Sandra Lee, Fengmin Zhao, Ahmad A. Tarhini, Kim A. Margolin, Marc S. Ernstoff, Michael B. Atkins, Gary I. Cohen, Theresa L. Whiteside, Lisa H. Butterfield, and John M. Kirkwood

Link

Clinical Utility of a Plasma Protein Classifier for Indeterminate Lung Nodules, Anil Vachani, Zane Hammoud, Steven Springmeyer, Neri M. Cohen, Dao Nguyen, Christina Williamson, Sandra Starnes, Stephen Hunsucker, Scott Law, Xiao-Jun Li, Alexander Porter, and Paul Kearney